Calcium indirectly regulates immunochemical reactivity and functional activities of the N-domain of thrombospondin-1

Matrix Biology

Volumn 27, Issue 4, 2008, Pages 339-351

  Calzada, Maria J ^a   Kuznetsova, Svetlana A ^a   Sipes, John M ^a   Rodrigues, Rui G ^a   Cashel, Jo Anne ^a   Annis, Douglas S ^b   Mosher, Deane F ^b   Roberts, David D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Calcium binding; Cell adhesion; Conformational epitopes; Extracellular matrix; Integrin recognition; Thrombospondin 1

Indexed keywords

CALCIUM; FIBRONECTIN; HEPARIN; MONOCLONAL ANTIBODY; PROTEIN; RECOMBINANT PROTEIN; SULFATIDE; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA STIMULATED GENE 6 PROTEIN; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 4;

AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; BINDING KINETICS; CALCIUM BINDING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; REGULATORY MECHANISM;

ANTIBODIES; CALCIUM; CATIONS, DIVALENT; CELL ADHESION; CELL ADHESION MOLECULES; EPITOPES; FIBRONECTINS; HUMANS; IMMUNOCHEMISTRY; INTEGRIN ALPHA3BETA1; LIGANDS; PROTEIN BINDING; THROMBOSPONDIN 1;

EID: 43049106796     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.12.002     Document Type: Article

References (61)

1. Akiyama S.K., and Yamada K.M. The interaction of plasma fibronectin with fibroblastic cells in suspension. J. Biol. Chem. 260 (1985) 4492-4500
2. Anilkumar N., Annis D.S., Mosher D.F., and Adams J.C. Trimeric assembly of the C-terminal region of thrombospondin-1 or thrombospondin-2 is necessary for cell spreading and fascin spike organisation. J. Cell. Sci. 115 (2002) 2357-2366
3. Annis D.S., Murphy-Ullrich J.E., and Mosher D.F. Function-blocking anti-thrombospondin-1 monoclonal antibodies. J. Thromb. Haem. 4 (2006) 459-468
4. Annis D.S., Gunderson K.A., and Mosher D.F. Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations. J. Biol. Chem. 282 (2007) 27067-27075
5. Bornstein P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107 (2001) 929-934
6. Calzada M.J., and Roberts D.D. Novel integrin antagonists derived from thrombospondins. Curr. Pharm. Des. 11 (2005) 849-866
7. Calzada M.J., Annis D.S., Zeng B., Marcinkiewicz C., Banas B., Lawler J., Mosher D.F., and Roberts D.D. Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J. Biol. Chem. 279 (2004) 41734-41743
8. Carlson C.B., Bernstein D.A., Annis D.S., Misenheimer T.M., Hannah B.L., Mosher D.F., and Keck J.L. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat. Struct. Mol. Biol. 12 (2005) 910-914
9. Carlson, C.B., Lawler, J., Mosher, D.F., in press. Structures of thrombospondins. Cell. Mol. Life Sci.
10. Chandrasekaran L., He C.-Z., Al-Barazi H.O., Krutzsch H.C., Iruela-Arispe M.L., and Roberts D.D. Cell contact-dependent activation of a3b1 integrin modulates endothelial cell responses to thrombospondin-1. Mol. Biol. Cell 11 (2000) 2885-2900
11. Chandrasekaran S., Guo N., Rodrigues R.G., Kaiser J., and Roberts D.D. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cella are mediated by a3b1 integrin and regulated by insulin-like growth factor-1 and CD98. J. Biol. Chem. 274 (1999) 11408-11416
12. Coller B.S., Peerschke E.I., Scudder L.E., and Sullivan C.A. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J. Clin. Invest. 72 (1983) 325-338
13. Dardik R., and Lahav J. Multiple domains are involved in the interaction of endothelial cell thrombospondin with fibronectin. Eur. J. Biochem. 185 (1989) 581-588
14. Dardik R., and Lahav J. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin. Exp. Cell Res. 248 (1999) 407-414
15. Davis G.E., Bayless K.J., Davis M.J., and Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 156 (2000) 1489-1498
16. Day A.J., Aplin R.T., and Willis A.C. Overexpression, purification, and refolding of link module from human TSG-6 in Escherichia coli: effect of temperature, media, and mutagenesis on lysine misincorporation at arginine AGA codons. Protein Expr. Purif. 8 (1996) 1-16
17. Dixit V.M., Grant G.A., Santoro S.A., and Frazier W.A. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J. Biol. Chem. 259 (1984) 10100-10105
18. Dixit V.M., Galvin N.J., KM O.R., and Frazier W.A. Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. J. Biol. Chem. 261 (1986) 1962-1968
19. Frelinger III A.L., Du X.P., Plow E.F., and Ginsberg M.H. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J. Biol. Chem. 266 (1991) 17106-17111
20. Galvin N.J., Dixit V.M., KM O.R., Santoro S.A., Grant G.A., and Frazier W.A. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J. Cell Biol. 101 (1985) 1434-1441
21. Galvin N.J., Vance P.M., Dixit V.M., Fink B., and Frazier W.A. Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. J. Cell Biol. 104 (1987) 1413-1422
22. Good D.J., Polverini P.J., Rastinejad F., Le B.M., Lemons R.S., Frazier W.A., and Bouck N.P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6624-6628
23. Guo N.H., Krutzsch H.C., Nègre E., Vogel T., Blake D.A., and Roberts D.D. Heparin-and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3040-3044
24. Hannah B.L., Misenheimer T.M., Annis D.S., and Mosher D.F. A polymorphism in thrombospondin-1 associated with familial premature coronary heart disease causes a local change in conformation of the Ca2+-binding repeats. J. Biol. Chem. 278 (2003) 8929-8934
25. Hannah B.L., Misenheimer T.M., Pranghofer M.M., and Mosher D.F. A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding. J. Biol. Chem. 279 (2004) 51915-51922
26. Hogg P.J. Disulfide bonds as switches for protein function. Trends Biochem. Sci. 28 (2003) 210-214
27. Huang E.M., Detwiler T.C., Milev Y., and Essex D.W. Thiol-disulfide isomerization in thrombospondin: effects of conformation and protein disulfide isomerase. Blood 89 (1997) 3205-3212
28. Hughes P.E., and Pfaff M. Integrin affinity modulation. Trends Cell Biol. 8 (1998) 359-364
29. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
30. Kaesberg P.R., Ershler W.B., Esko J.D., and Mosher D.F. Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan. J. Clin. Invest. 83 (1989) 994-1001
31. Kahmann J.D., Koruth R., and Day A.J. Method for quantitative refolding of the link module from human TSG-6. Protein Expr. Purif. 9 (1997) 315-318
32. Krutzsch H.C., Choe B., Sipes J.M., Guo N., and Roberts D.D. Identification of an a3b1 integrin recognition sequence in thrombospondin-1. J. Biol. Chem. 274 (1999) 24080-24086
33. Kuznetsova S.A., Day A.J., Mahoney D.J., Rugg M.S., Mosher D.F., and Roberts D.D. The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor. J. Biol. Chem. 280 (2005) 30899-30908
34. Kuznetsova S.A., Issa P., Perruccio E.M., Zeng B., Sipes J.M., Ward Y., Seyfried N.T., Fielder H.L., Day A.J., Wight T.N., and Roberts D.D. Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells. J. Cell Sci. 119 (2006) 4499-4509
35. Kvansakul M., Adams J.C., and Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. Embo. J. 23 (2004) 1223-1233
36. Lawler J., and Simons E.R. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J. Biol. Chem. 258 (1983) 12098-12101
37. Lawler J., Derick L.H., Connolly J.E., Chen J.H., and Chao F.C. The structure of human platelet thrombospondin. J. Biol. Chem. 260 (1985) 3762-3772
38. Li Z., Calzada M.J., Sipes J.M., Cashel J.A., Krutzsch H.C., Annis D., Mosher D.F., and Roberts D.D. Interactions of thrombospondins with a4b1 integrin and CD47 differentially modulate T cell behavior. J. Cell Biol. 157 (2002) 509-519
39. Mao Y., and Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 24 (2005) 389-399
40. Marti G.E., Magruder L., Schuette W.E., and Gralnick H.R. Flow cytometric analysis of platelet surface antigens. Cytometry 9 (1988) 448-455
41. Misenheimer T.M., and Mosher D.F. Calcium ion binding to thrombospondin 1. J. Biol. Chem. 270 (1995) 1729-1733
42. Misenheimer T.M., Huwiler K.G., Annis D.S., and Mosher D.F. Physical characterization of the procollagen module of human thrombospondin 1 expressed in insect cells. J. Biol. Chem. 275 (2000) 40938-40945
43. Misenheimer T.M., Hannah B.L., Annis D.S., and Mosher D.F. Interactions among the three structural motifs of the C-terminal region of human thrombospondin-2. Biochemistry 42 (2003) 5125-5132
44. Mould A.P., Akiyama S.K., and Humphries M.J. The inhibitory anti-beta1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function. J. Biol. Chem. 271 (1996) 20365-20374
45. Munson P.J., and Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107 (1980) 220-239
46. Narizhneva N.V., Byers-Ward V.J., Quinn M.J., Zidar F.J., Plow E.F., Topol E.J., and Byzova T.V. Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction. J. Biol. Chem. 279 (2004) 21651-21657
47. Newham P., Craig S.E., Clark K., Mould A.P., and Humphries M.J. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes. J. Immunol. 160 (1998) 4508-4517
48. Roberts D.D., Haverstick D.M., Dixit V.M., Frazier W.A., Santoro S.A., and Ginsburg V. The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J. Biol. Chem. 260 (1985) 9405-9411
49. Roberts D.D., Liotta L.A., and Ginsburg V. Gangliosides indirectly inhibit the binding of laminin to sulfatides. Arch. Biochem. Biophys. 250 (1986) 498-504
50. Roberts D.D., Cashel J., and Guo N. Purification of thrombospondin from human platelets. J. Tissue Cult. Methods 16 (1994) 217-222
51. Rodrigues R.G., Guo N., Zhou L., Sipes J.M., Williams S.B., Templeton N.S., Gralnick H.R., and Roberts D.D. Conformational regulation of the fibronectin binding and a3b1 integrin-mediated adhesive activities of thrombospondin-1. J. Biol. Chem. 276 (2001) 27913-27922
52. Silverstein R.L., Leung L.L., Harpel P.C., and Nachman R.L. Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J. Clin. Invest. 74 (1984) 1625-1633
53. Slane J.M., Mosher D.F., and Lai C.S. Conformational change in thrombospondin induced by removal of bound Ca2+. A spin label approach. FEBS Lett. 229 (1988) 363-366
54. Speziale M.V., and Detwiler T.C. Free thiols of platelet thrombospondin. Evidence for disulfide isomerization. J. Biol. Chem. 265 (1990) 17859-17867
55. Sun X., Skorstengaard K., and Mosher D.F. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin. J. Cell Biol. 118 (1992) 693-701
56. Taraboletti G., Roberts D., Liotta L.A., and Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111 (1990) 765-772
57. Tomasini-Johansson B.R., Annis D.S., and Mosher D.F. The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol. 25 (2006) 282-293
58. Topol E.J., McCarthy J., Gabriel S., Moliterno D.J., Rogers W.J., Newby L.K., Freedman M., Metivier J., Cannata R., O'Donnell C.J., Kottke-Marchant K., Murugesan G., Plow E.F., Stenina O., and Daley G.Q. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104 (2001) 2641-2644
59. Vischer P., Feitsma K., Schon P., and Volker W. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. Eur. J. Cell Biol. 73 (1997) 332-343
60. Vuillard L., Clezardin P., and Miller A. Models of human platelet thrombospondin in solution. A dynamic light-scattering study. Biochem. J. 275 (1991) 263-266
61. Yu H., Tyrrell D., Cashel J., Guo N.H., Vogel T., Sipes J.M., Lam L., Fillit H.M., Hartman J., Mendelovitz S., Panel A., and Roberts D.D. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1. Arch. Biochem. Biophys. 374 (2000) 13-23